Xuebin B. Han - Publications

Conceptual Reconsideration of the Classification of Pulmonary Hypertension: From 5 Groups to 2 Groups.

Journal: JACC. Asia

Published: November 20, 2025

Safety and Efficacy of Intravascular Lithotripsy System: A Prospective, Multicenter Clinical Trial (The VIGOUR Study).

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Published: August 21, 2025

Multiply doses of FDC of rosuvastatin and ezetimibe versus rosuvastatin monotherapy in Chinese patients with hypercholesterolemia (ROSE-CH): multicenter, randomized-controlled trial.

Journal: Lipids in health and disease

Published: April 15, 2025

A new comprehensive parameter combining residual C-reactive protein and neutrophil risk predicting adverse events in Chinese patients after percutaneous coronary intervention: A multi-center prospective cohort study.

Journal: Chinese medical journal

Published: March 27, 2025

Recaticimab in adult heterozygous familial hypercholesterolaemia (REMAIN-3): a multicentre, randomized, double-blind, placebo-controlled Phase 3 study.

Journal: Cardiovascular research

Published: December 09, 2024

Changes of lung function and inflammatory factors in rat models of coal workers' pneumoconiosis

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: September 02, 2024

Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial.

Journal: Atherosclerosis

Published: August 23, 2024

Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia: The Phase 3 REMAIN-1 Randomized Trial.

Journal: Journal of the American College of Cardiology

Published: May 23, 2024

Safety, efficacy, and reliability evaluation ofa novel small-diameter defibrillation lead: Global LEADR pivotal trial results.

Journal: Heart rhythm

Published: March 06, 2024

Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Primary Prevention Indications: A Prospective Observational Cohort Study.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: February 24, 2024

Variation and disparity in awareness of atrial fibrillation in China: A national cross-sectional study.

Journal: International journal of cardiology

Published: December 18, 2023

Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry.

Journal: Scientific reports

Published: October 18, 2023